Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by BluePoint Laboratories, priced at $2.9636 per ML under NDC 68001053069. Its NADAC has been published 218 times since Aug 3, 2022.
FDA first approved this application on Apr 4, 2019.
Strength
2 mg/mL
Manufacturer
BluePoint LaboratoriesNDC
68001053069
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209995FDA Approved
4/4/2019
On Market Since
4/8/2022
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 218 times since Aug 3, 2022, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9636 per ML |
|---|---|
| All-time high | $3.9682 (Feb 15, 2023) |
| All-time low | $2.8218 (Aug 17, 2022) |
| 52-week high | $3.6822 |
| 52-week low | $2.9636 |
| Median price | $3.3654 |
| Average price | $3.3637 |
| Largest weekly change | -25.4% (Aug 17, 2022) |
| Weeks tracked | 218 |
| Tracking since | Aug 3, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OLOPATADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by BluePoint Laboratories, is $2.9636 per ML (NDC 68001053069), effective Sep 30, 2026.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 21.7%. It has been tracked across 218 weekly CMS publications since Aug 3, 2022.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Aug 3, 2022, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.8218 (Aug 17, 2022) to a high of $3.9682 (Feb 15, 2023), with a median of $3.3654 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLOPATADINE HCL 0.2% EYE DROP, is $1.9835 per ML — about 33% below OLOPATADINE HCL 0.2% EYE DROP.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 68001053069) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.